Subscribe to our
24/7 Wall St.
FREE Stock Alerts
 
Name:
 
Email:
 

Recent Posts

October 2008

Sun Mon Tue Wed Thu Fri Sat
      1 2 3 4
5 6 7 8 9 10 11
12 13 14 15 16 17 18
19 20 21 22 23 24 25
26 27 28 29 30 31  

Older Archives

« Cramer's Biotech Zombie Looking Up | Main | Goldman Sachs Research Summary (MAR 19, 2007) »

March 19, 2007

Full Research Summary (MAR 19, 2007)

ACC cut to Mkt Perform at Wachovia.
ACTS cut to Peer Perform at Bear Stearns.
ALTI started as Buy at Merriman Curhan Ford.
ANAD started as Buy at Jefferies.
ANN raised to Mkt Perform at Piper Jaffray.
ARXT raised to Strong Buy at First Albany.
BEAS raised to Buy at UBS.
CEL started as Buy at Jefferies.
CERN cut to Peer Perform at Bear Stearns.
COGN raised to Overweight at Morgan Stanley.
FCX raised to Outperform at Bear Stearns.
GDP started as Overweight at JPMorgan.
GIII started as Outperform at Cowen & Co.
GT raised to Buy at KeyBanc/McDonald.
HRB raised to Overweight at Thomas Weisel.
JASO started as Outperform at CIBC.
JASO started as Outperform at Piper Jaffray.
KFT raised to Neutral at Prudential.
JTX cut to Underweight at Thomas Weisel.
NETL started as Sector Perform at CIBC.
OMM cut to Hold at Jefferies.
RSH cut to Underweight at Morgan Stanley.
SEPR cut to Underperform at FBR.
SIRF raised to Buy at Oppenheimer.
SNTA started as Equal Weight at Lehman.
SNTA started as Outperform at Bear Stearns.
TWTI started as Equal Weight at First Analysis.
UQM started as Buy at Merriman Curhan Ford.
WAG raised to Overweight at JPMorgan.
ZRAN started as Hold at WR Hambrecht.

Jon C. Ogg
March 19, 2007

Jon Ogg can be reached at jonogg@247wallst.com; he does not own securities in the companies he covers.

Subscribe to this feed
  Enter a Symbol:

Advertising

  • Google


    FT.com